1. Home
  2. MGIC vs CGEN Comparison

MGIC vs CGEN Comparison

Compare MGIC & CGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Magic Software Enterprises Ltd.

MGIC

Magic Software Enterprises Ltd.

HOLD

Current Price

$26.95

Market Cap

990.3M

Sector

Technology

ML Signal

HOLD

Logo Compugen Ltd.

CGEN

Compugen Ltd.

HOLD

Current Price

$1.63

Market Cap

143.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MGIC
CGEN
Founded
1983
1993
Country
Israel
Israel
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
990.3M
143.1M
IPO Year
1991
2000

Fundamental Metrics

Financial Performance
Metric
MGIC
CGEN
Price
$26.95
$1.63
Analyst Decision
Buy
Strong Buy
Analyst Count
2
1
Target Price
$18.00
$4.00
AVG Volume (30 Days)
39.1K
458.5K
Earning Date
11-18-2025
11-10-2025
Dividend Yield
2.22%
N/A
EPS Growth
16.15
N/A
EPS
0.81
N/A
Revenue
$603,216,000.00
$6,903,000.00
Revenue This Year
$12.87
N/A
Revenue Next Year
$6.23
$231.15
P/E Ratio
$33.45
N/A
Revenue Growth
12.65
N/A
52 Week Low
$11.36
$1.13
52 Week High
$27.44
$2.66

Technical Indicators

Market Signals
Indicator
MGIC
CGEN
Relative Strength Index (RSI) 57.18 54.27
Support Level $26.61 $1.43
Resistance Level $27.31 $1.73
Average True Range (ATR) 0.70 0.07
MACD -0.08 0.02
Stochastic Oscillator 80.65 63.33

Price Performance

Historical Comparison
MGIC
CGEN

About MGIC Magic Software Enterprises Ltd.

Magic Software Enterprises Ltd is a software development company. The company's operating segment includes Software Services and IT Professional Services. The company generates maximum revenue from the IT Professional Services segment. IT Professional Services segment offers IT services in the areas of infrastructure design and delivery, application development, technology planning and implementation services, communications services and solutions, as well as supplemental outsourcing services. Geographically, it derives a majority of revenue from the United States and also has a presence in Israel, Europe, Japan, and Other countries.

About CGEN Compugen Ltd.

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.

Share on Social Networks: